DrugRisk Update: Yaz Maker Reports Over 13,000 Lawsuits as Settlements Continue
The Drug Resource Center is the premiere source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com.
Denver, CO (PRWEB) March 18, 2013
The birth control safety advocates at DrugRisk.com are alerting women who have taken the oral contraceptives Yaz or Yasmin of new information on the site indicating Bayer has received injury claims from over 13,000 people, and is continuing to provide compensation for certain patients.
“DrugRisk´s goal is to improve the safety of those taking prescription drugs by sharing the latest drug warnings, recalls, studies and litigation news. Many of those who have taken Yaz or Yasmin may still be able to get legal help for blood clots, even if they think time has expired,” explains DrugRisk representative Ryan Mayer.
The resource center contains studies from the British Medical Journal and FDA, who have warned that birth control pills containing the chemical drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.*
DrugRisk has also discovered that due to the number of those affected filing a Yaz lawsuit, cases were consolidated to a special federal Multi-District Litigation court in Illinois. The case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).
Now, the resource center has obtained Bayer´s latest report to investors, which discloses the company faces Yaz lawsuits over side effects from as many as 13,600 claimants**.
Bayer also disclosed they have settled around 4,800 claims involving blood clot injuries like deep vein thrombosis (DVT) or pulmonary embolism, and will continue to evaluate such claims for settlement on a case-by-case basis**.
Fortunately, patients who have suffered blood clot injuries but have yet to file a case can still do so. Anyone affected by a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal options.
Due to the specialized nature of federal MDL drug injury cases, DrugRisk cautions that patients should seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
*British Medical Journal, October 25, 2011, University of Copenhagen; FDA, October 27, 2011, “Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints”
**Bayer 2012 Annual Report, Consolidated Financial Statement, Legal Notes, February 28, 2013
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebyaz-lawsuit/side-effects-settlement/prweb10534750.htm